TCT-700 Transcarotid Transcatheter Aortic Valve Replacement: Feasibility and Safety  by Mylotte, Darren et al.
J O U R N A L O F T H E A M E R I C A N C O L L E G E O F C A R D I O L O G Y , V O L . 6 6 , N O . 1 5 , S U P P L B , 2 0 1 5 B285BACKGROUND The high prevalence of signiﬁcant coronary artery
disease (CAD) in patients referred to trans-catheter aortic valve
replacement (TAVR) has been demonstrated by multiple large studies.
Whereas computer tomography angiography (CTA) is becoming an
indispensable component of TAVR work up, CAD assessment by CTA
has been challenging in patients undergoing TAVR due to the heavy
calciﬁcation burden and beta blockers use restrictions. Computed
fractional ﬂow reserve (FFR CT) has been shown to improve diag-
nostic accuracy and discrimination compared to CTA alone for the
diagnosis of hemodynamically signiﬁcant coronary artery disease
when compared to invasive FFR. However, its performance in TAVR
population is still unknown. The goal of this study is to determine the
incremental beneﬁt and to assess the diagnostic ability of FFR CT
derived from CTA for CAD assessment in patients referred to TAVR
over CTA alone as compared to invasive coronary angiography (ICA).
METHODS A total of 19 consecutive CTA exams with at least one non
diagnostic major coronary segment due to calcium presence were pro-
cessed by HeartFlow, Inc. to compute FFR CT. The major coronary artery
branches were divided in 10 segments per patient, and when deemed
visually interpretable and categorized in binomial fashion as non-signif-
icant or signiﬁcant coronary disease using 50% cutoff value. Results were
then compared to ICA results that were graded by different expert in
similar fashion using more than 70% stenosis for signiﬁcant disease.
Figure 1: (A) CTA showing uninterpretable LM and proximal LAD seg-
ments due to calciﬁcation blooming. (B) FFR CT of the same segments
quantiﬁed from the same set of CTA images is interpretable, revealing
normal values of 0.96 and 0.83, respectively. (C) ICA demonstrates
normal LM and mild stenosis of the proximal portion of the LAD.
RESULTS At patient level, out of the 19 cases, 11 (58%) were found
interpretable by HeartFlow and 8 (42%) uninterpretable for FFR CT
analysis. At segment level analysis of the 11 interpretable cases, the
sensitivity and speciﬁcity of FFR CT compared to ICA were 100% and
90%, respectively.
CONCLUSIONS FFR CT analysis can enhance CTA diagnostic ability to
rule out signiﬁcant CAD while maintaining high sensitivity. If these
ﬁndings are reproducible in larger series, a signiﬁcant percent of
TAVR candidates would be spared from unnecessary ICA.
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BACKGROUND The Direct Flow Medical transcatheter aortic valve
system has a non-metallic design with a pressurized supportstructure, which allows precise positioning, retrieval and full hemo-
dynamic assessment of valve performance prior to permanent im-
plantation. The Direct Flow Italian registry is a nationwide registry
enrolling patients treated with the Direct Flow Device in the aortic
position since early 2012 to evaluate outcomes of the device in a real
world setting.
METHODS A group of 142 consecutive patients treated after February
2012 in 5 Italian centers has been enrolled in the registry.
RESULTS Mean age was 82.86.1 years, mean EuroSCORE was
20.415.3%. Patient comorbidities were: COPD in 27.8%; moderate or
severe kidney disease in 31%; peripheral vessel disease in 33.3%;
previous MI in 19.1%, previous CABG in 17.0%; 67.9% of patients were
in class NYHA 3 or 4. At a median follow up of 11.2 (IQR 3.0-19.0)
months, 9.2% of patient died and the stroke rate was 2.1%. PM rate
within 30 days of the procedure was 12.7%. Vascular complications
occurred in 2.1%, conversion to cardiac surgery in 1.4% and the Direct
Flow device was retrieved to switch to a different valve in 2.1% of
patients. A procedural learning curve was apparent and mean ﬂuo-
roscopy times signiﬁcantly decreased with greater operator experi-
ence from 45.422.8 to 29.68.6 minutes when comparing the ﬁrst
and fourth quartiles (p¼0.02). Moderate or severe PV leak at the last
available echo at a median follow up of more than 11 months was
present in only 2.1% of cases.
CONCLUSIONS The Direct Flow Medical transcatheter aortic valve
system demonstrates excellent real-world outcomes in high-risk pa-
tients with severe aortic stenosis, with an overall low death stroke and
pacemaker rate and a good valve performance.
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BACKGROUND A considerable proportion of potential TAVR candi-
dates have challenging vascular anatomies that is unsuitable for
transfemoral TAVR. Transcarotid TAVR access may be an option for
these patients.
METHODS The French Transcarotid TAVR Registry is a voluntary
database that has prospectively collected patient demographics,
clinical and procedural characteristics, and clinical outcomes on pa-
tients undergoing transcarotid TAVR since 2009. All patients under-
went pre-operative multimodal imaging assessment, including
multislice computed tomography and cerebral magnetic resonance
angiography. All outcomes are reported according to the updated
Valve Academic Research Consortium.
RESULTS Among 96 patients undergoing transcarotid TAVR in France
at 3 sites between April 2009 and December 2013, the mean age was
79.49.2 years and the average STS PROM score was 7.14.1%. Suc-
cessful carotid artery access was achieved in all patients. The Med-
tronic CoreValve and Edwards SAPIEN THV were implanted in 89
(92.7%) and 7 (7.3%) patients, respectively. Procedural complications
included: THV embolization (3.1%); implantation of a second THV
(3.1%); and cardiac tamponade due to left ventricular wire perforation
(4.2%). There were no major bleeds or major vascular complications
related to the carotid access site. There were 3 (3.1%) procedural
deaths and 6 deaths (6.3%) at 30-days. There were 3 (3.1%) cases of
VARC-deﬁned in-hospital stroke (n¼0) or TIA (n¼3). No patient ach-
ieved the criteria for stroke and none had new ischemic lesions on
neuroimaging. At 30-days, a further 3 TIAs were observed, giving an
overall stroke/TIA rate of 6.3%.
CONCLUSIONS Transcarotid vascular access for TAVR is feasible and
is associated with encouraging short and medium-term clinical out-
comes. Prospective studies are required to ascertain if transcarotid
TAVR yields equivalent safety and efﬁcacy to other non-femoral
vascular access routes.
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